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Background: Fibroadenomas are the second most common breast pathology occurring in young women under the
age of 35 years old. Fibroadenomas can be classified as simple or complex according to histological features. Complex
fibroadenomas differ from simple fibroadenomas because of the presence of cysts (3 mm), sclerosing adenosis,
epithelial calcifications, or papillary apocrine changes. Most fibroadenomas are clinically identifiable. In 25% of cases,
fibroadenomas are non-palpable and are diagnosed with mammography and ultrasound. Differential diagnosis with
well differentiated breast cancer is often necessary, particularly with medullary or mucinous tumors. Calcification
findings within fibroadenomas by mammogram have to be investigated. The age of a lump is usually reflected by
calcifications. Microcalcification can hide foci of carcinoma in situ when they are small, branching type, and
heterogeneous. However, many morphological possibilities may not be reliable for deciding whether a certain
calcification is the product of a malignant or a benign process. From a radiological point of view, fibroadenomas
containing foci of carcinoma in situ can be indistinguishable from benign lesions, even if the incidence of carcinoma
within fibroadenomas is estimated as 0.1–0.3%, and it could be a long-term risk factor for invasive breast cancer.
Case presentation: A 44-year-old woman presented with a 1.5-cm palpable, smooth, mobile lump in the lower-inner
quadrant of her right breast. Standard mediolateral oblique and craniocaudal mammograms showed a cluster of
eccentric popcorn-like calcifications within the fibroadenoma. After lumpectomy, a definitive histological examination
confirmed the intra-operative diagnosis of a benign mass. However, lobular intraepithelial neoplasia foci were found,
surrounded by atypical lobular hyperplasia.
Conclusions: The possibility of an old benign breast lump might be supported by fine needle aspiration biopsy or core
biopsy before initiating follow-up. According to our experience, when patients are older than 40 years and have a
familial history of breast cancer, we prefer to carry out lumpectomy with follow up to avoid the risk of underestimation
in situ foci within the lump.
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Fibroadenomas are the second most common breast path-
ology, following fibrocystic disease, and occur in women
younger than 35 years old. The peak age of incidence is in
the third decade. Fibroadenoma is a benign breast tumor
that is effectively treated by local excision consisting of
lumpectomy. Fibroadenomas can be classified as simple or
complex according to histological features. Complex fibro-
adenomas differ from simple fibroadenomas because of* Correspondence: emanuelaexpo@hotmail.it
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reproduction in any medium, provided the orthe presence of cysts (>3 mm), sclerosing adenosis, epithe-
lial calcifications, or papillary apocrine changes. The stroma
in young fibroadenomas is usually mostly cellular, and as
these lumps age they tend to become less cellular and more
sclerotic. Epithelial elements atrophy and calcification often
develops. Most fibroadenomas are clinically identifiable,
whereas in 25% of cases, fibroadenomas are non-palpable
and are diagnosed with mammography and ultrasound [1].
Differential diagnosis with well differentiated breast cancer
is often necessary, particularly with medullary or mucinous
tumors. Calcification findings within fibroadenomas by
mammogram often need to be investigated. The age of a
lump is usually reflected by calcifications. Calcifications oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mogram and are always a sign of a previous or ongoing
breast tissue alteration. Calcifications are usually benign
and their frequency increases with age. Active cell secre-
tion, cellular necrotic debris, inflammation, trauma or ra-
diation are the most usual reasons for the formation of
calcifications. To standardize mammographic reporting,
the American College of Radiology implemented the
Breast Imaging Reporting and Database System (BIRADS).
For calcifications, BIRADS takes into account distribution
within the breast and patterns. Calcifications may be a
sign of benign changes but they can also disclose a
yet nonpalpable malignant process. There are “benign-
looking” calcifications that may show a malignant process
and “suspicious-looking” findings that may be less malig-
nant than “benign-looking” ones. Regardless of the final
diagnosis, calcifications should be assessed according to
shape, size, density, number, distribution, and associated
findings. Morphology alone in some well-defined instances
(popcorn, eggshell or tram-track calcification) can be used
to identify the benign nature of a breast process. However,
certain morphologies (branching and casting types) will al-
ways be highly suspicious. However, there are many mor-
phological possibilities, which are unreliable for deciding
whether a certain calcification is the product of a malignant
or a benign process [2]. Accordingly, popcorn-like large
(>2 mm) calcifications may be considered “benign-looking”,
whereas small, branching type and heterogeneous calcifica-
tions can express foci of carcinoma in situ. From a radio-
logical point of view, fibroadenoma containing foci of
carcinoma in situ can be indistinguishable from benign le-
sions, even if the incidence of carcinoma within fibroaden-
omas is estimated as 0.1–0.3% [3]. Moreover, it could be a
long-term risk factor for invasive breast cancer. Seven stud-
ies have attempted to confirm the breast cancer risk associ-
ated with fibroadenomas. Dupont et al. and McDivittFigure 1 Popcorn-like calcifications shown by mammogram.et al. are considered to provide the strongest evidence,
and showed that the relative risk for excised fibroaden-
omas without hyperplasia ranges from 1.48–1.7, that for
fibroadenomas with hyperplasia is 3.47–3.7, and that for
fibroadenomas with hyperplasia and atypia is 6.9–7.29,
persisting for more than 20 years [4,5]. The other five
studies by Levi et al., Ciatto et al., Moskowitz et al., Carter
et al., and Levshin et al., are considered to provide weaker
evidence, although they showed similar results [6,7]. None
of these results could be used to quantify the risk of ex-
cised, non-excised, and asymptomatic fibroadenoma. The
overall risk of invasive breast cancer is 2.17 times higher
among patients with complex fibroadenomas than among
controls (95% confidence interval [CI], 1.5 to 3.2) [4]. The
relative risk increases to 3.10 among patients with com-
plex fibroadenomas (95% CI, 1.9 to 5.1) and remains ele-
vated for decades after diagnosis. Patients with benign
proliferative disease in the parenchyma adjacent to the
fibroadenoma have a relative risk of 3.88 (95% CI, 2.1 to
7.3). Patients with a familial history of breast cancer in
whom complex fibroadenomas are diagnosed have a rela-
tive risk of 3.72 compared with controls with a family
history (95% CI, 1.4 to 10) [4]. Patients with simple fibro-
adenomas and no family history of breast cancer do not
have an increased risk. Lobular carcinoma in situ (LCIS)
of the breast is commonly identified as an incidental find-
ing in breast biopsies performed because of either a
mammographic abnormality or a palpable mass. Lobular
neoplasia (LN) includes atypical lobular hyperplasia
(ALH) and LCIS. The significance of lobular intraepithelial
neoplasia (LIN), which includes lobular carcinoma in situ
(LCIS) and ALH of the breast, remains uncertain. LN is
often an incidental finding on breast core needle biopsy or
open biopsy, and management remains controversial [8].
Initially regarded as a pre-invasive form of breast cancer
analogous to ductal carcinoma in situ, LCIS is treated byFigure 2 Hypoechoic lump at breast ultrasound.
Figure 3 Intraoperative specimen.
Figure 5 Sample stained with hematoxylin and eosin showing
LCIS within the fibroadenoma.
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vasive carcinoma in both breasts, bilateral mastectomy was
advocated by some authors [9]. More recent studies sug-
gest that LCIS is a marker for increased risk rather than a
true precursor of invasive carcinoma, and this allows a
more conservative approach [10]. LCIS is associated with
an increased risk of breast cancer, ranging from a three- to
four-fold increased risk with ALH, and up to an eight- to
ten-fold increased risk with LCIS [11,12].Figure 4 Sample stained with hematoxylin and eosin staining
showing a fibroadenoma.Case presentation
A 44-year-old woman with a familial history of breast
cancer presented with a 1.5 cm palpable, smooth, mo-
bile lump in the lower-inner quadrant of her right
breast. Standard mediolateral oblique and craniocaudal
mammograms showed a cluster of eccentric popcorn-
like calcifications within the fibroadenoma (Figure 1).
Breast ultrasound showed an oval, smooth bordered
hypoechoic lump with some hyperechoic spots (Figure 2).
Fine needle aspiration biopsy was negative for malignant
cells and showed a complex fibroadenoma cellular pattern.
Considering the familial history of cancer, the patient’s age
and mammographic calcifications findings, lumpectomy
was performed. Intra-operative frozen sections supported
our pre-operative clinical-instrumental diagnosis of com-
plex fibroadenoma. The final histological report macro-
scopically showed a brown-yellowish nodular lesion of
1.5 × 1.3 cm, capsulated with a tough elastic consistency
(Figure 3). The fibroadenoma was sliced into 2-mm-thick
samples and stained with hematoxylin-eosin. Microscopic-
ally, definitive sections confirmed the intra-operative diag-
nosis of fibroadenoma (Figure 4), but LIN foci were found,
surrounded by ALH (Figure 5). LIN constituted an inde-
pendent entity and was not an extension of the fibroaden-
oma. Treatment for the patient consisted of only surgery.
Six monthly ultrasound, annual mammography, and a clin-
ical follow-up were carried out. After 5 years of followup,
neither local recurrence nor contralateral breast cancer
ever developed.
Conclusions
The possibility of an old benign breast lump might be sup-
ported by fine needle aspiration biopsy or core biopsy be-
fore initiating follow-up. According to our experience,
when patients are older than 40 years and have a familial
history of breast cancer, we prefer to perform lumpectomy
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foci within the lump. Even if the incidence of carcinoma
within fibroadenoma is low, the long term risk of progres-
sion toward invasive breast cancer is unknown. The differ-
ence between benign and malignant lumps is determined
by DNA mutations. The loss of heterozygosity, achieved
by the passing of time, appears to be the most important
factor to consider during breast intraepithelial neoplasm
development. We strongly recommend removing old fib-
roadenomas, even though they present with “benign-
looking calcifications” in patients with a familial history of
breast cancer, because of the chance of finding lobular or
ductal carcinoma foci within them. LCIS within a breast
fibroadenoma is a rare entity. In light of the recent litera-
ture showing that carcinomas arising within a fibroaden-
oma have the same biological behavior as those arising
independently, their management should be the same.
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